BioCentury | Oct 20, 2017
Regulation

Realities of real-world evidence

...4,233 GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) Dec 2016 HARMONY Outcomes Pragmatic Determine the effect of Tanzeum albiglutide...
BioCentury | Jul 28, 2017
Company News

GSK pruning pipeline

...ownership of these assets." GSK will also "progressively withdraw its support" for diabetes drug Tanzeum albiglutide...
BioCentury | Jul 26, 2017
Company News

GSK pruning pipeline, returning sirukumab rights to J&J

...ownership of these assets." GSK will also "progressively withdraw its support" for diabetes drug Tanzeum albiglutide...
...from 2Q16, and just above the £7.27 billion ($9.5 billion) consensus estimate. Chris Lieu single-tablet Tivicay dolutegravir/Edurant rilpivirine sirukumab Tanzeum GlaxoSmithKline...
BioCentury | Jun 8, 2015
Company News

GlaxoSmithKline sales and marketing update

...The German Institute for Quality and Efficiency in Health Care (IQWiG) said Tanzeum albiglutide from GlaxoSmithKline...
...metformin. The agency said the Tanzeum arm experienced fewer non-serious/non-severe adverse events but noted that Tanzeum...
...Tanzeum with at least two other blood-glucose lowering drugs and Tanzeum in combination with insulin. Tanzeum...
BioCentury | Jan 12, 2015
Finance

Buyside view XXIII: Milestones galore

...SLL Gilead Sciences Inc. (NASDAQ:GILD) Harvoni ledipasvir/sofosbuvir HCV Canada/EU/U.S. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) Tanzeum albiglutide (Eperzan...
BioCentury | Sep 1, 2014
Company News

GlaxoSmithKline sales and marketing update

...GlaxoSmithKline launched Tanzeum albiglutide in the U.S. to treat Type II diabetes as monotherapy or as...
...wholesale acquisition cost of 4 injections of 30 or 50 mg once-weekly Tanzeum is $325.96. Tanzeum...
...comprised of two copies of modified human GLP-1 fused in series to human albumin as Eperzan...
BioCentury | Aug 11, 2014
Strategy

Profusion of exclusions

...drugs could get excluded if companies lack time to negotiate, such as with GSK's Tanzeum albiglutide...
...could formally promote the drug, thus the determination could not be informed by physician experience. Tanzeum...
...Stendra avanafil Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL)/Vivus Inc. (NASDAQ:VVUS) ü Glucagon-like peptide-1 (GLP-1) receptor agonists Tanzeum albiglutide...
BioCentury | Jul 14, 2014
Finance

2Q Stock Wrap-Up: Large and in charge

...for maintenance treatment of airflow obstruction in COPD GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) FDA approves Tanzeum albiglutide...
BioCentury | Apr 21, 2014
Clinical News

Tanzeum albiglutide regulatory update

...FDA approved Tanzeum albiglutide from GlaxoSmithKline to treat Type II diabetes as monotherapy or as add-on...
...to comment on a timeline for starting the trial. The European Commission approved albiglutide as Eperzan...
...month (see BioCentury, March 31). GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Product: Tanzeum albiglutide ( Eperzan...
BioCentury | Apr 15, 2014
Company News

FDA approves GSK's albiglutide

...FDA approved Tanzeum albiglutide from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) to treat Type II diabetes as monotherapy...
...to treat Type II diabetes as monotherapy or as add-on therapy. GSK plans to launch Tanzeum...
...to comment on a timeline for starting the trial. The European Commission approved albiglutide as Eperzan...
Items per page:
1 - 10 of 81